|
The customer observed falsely elevated bilirubin on the architect c8000 analyzer.The following data was provided for a neonate: initial 22.47, repeated 16 mg dl.The patient was transferred to another hospital, however no negative impact to patient management was reported.
|
|
Further investigation of the customer issue included a review of the complaint text, a search for similar complaints, review of the design history file, review of field data, and a review of labeling.No adverse trend, non-conformances, potential non-conformances, or deviations were identified for the customer's issue.No return patient sample was available.Labeling was reviewed and found to be adequate.Historical performance of the reagent lot was evaluated using world wide data.The patient data was analyzed and within expected limits.Accurate and reproducible results are dependent upon properly functioning instruments and reagents, storage of product as directed, and good laboratory technique.Based on all available information and abbott diagnostics' complaint investigation no product deficiency was identified.
|